| Name | Title | Contact Details |
|---|---|---|
Kimberly MacKay |
Senior Vice President, General Counsel and Corporate Secretary | Profile |
Ryan Metz |
Associate General Counsel (Vice President) | Profile |
John Chippari |
Vice President, Regulatory Affairs | Profile |
Douglas Bruno |
Vice President and Associate General Counsel | Profile |
Park Dental Research Corp is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Zoasis is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
County Of Ripley is a Doniphan, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Brethet, Barnum and Associates, Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.